SCHEMBL19969306

SCHEMBL19969306

Cn1c(=O)c2[nH]c(CCCCCCO)nc2n(C)c1=O

nearest known ligand 0.72

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.72
CYP2C19 P33261 3/20 0.72
CYP1A2 P05177 1/20 0.72
POLB P06746 1/20 0.68
CYP3A4 P08684 3/20 0.66
NR2F2 P24468 1/20 0.65
CYP2D6 P10635 1/20 0.62
ALOX15 P16050 1/20 0.59
MAPK1 P28482 1/20 0.59
HSD17B10 Q99714 2/20 0.58
CASP1 P29466 1/20 0.58
CASP7 P55210 1/20 0.58
ADORA1 P30542 2/20 0.54
ADORA2A P29274 1/20 0.54
GAA P10253 1/20 0.51
MAPT P10636 1/20 0.51
PABPC1 P11940 1/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL26447496 1.00 ALDH1A1 (0.72) ALDH1A1CYP2C19CYP1A2POLBCYP3A4
SCHEMBL10652432 0.99 ALDH1A1 (0.74) ALDH1A1CYP2C19CYP1A2POLBCYP3A4
SCHEMBL6243622 0.94 ALDH1A1 (0.71) ALDH1A1CYP2C19CYP1A2POLBCYP3A4
SCHEMBL21765989 0.93 POLB (0.77) ALDH1A1CYP2C19CYP1A2POLBCYP3A4
SCHEMBL3455612 0.88 POLB (0.75) ALDH1A1CYP2C19CYP1A2POLBCYP3A4
SCHEMBL10394217 0.87 POLB (0.78) ALDH1A1CYP2C19CYP1A2POLBCYP3A4
SCHEMBL4222552 0.87 POLB (0.78) ALDH1A1CYP2C19CYP1A2POLBCYP3A4
SCHEMBL16084377 0.87 POLB (0.78) ALDH1A1CYP2C19CYP1A2POLBCYP3A4
SCHEMBL8665529 0.86 ALDH1A1 (0.68) ALDH1A1CYP2C19CYP1A2POLBCYP3A4
SCHEMBL9844925 0.86 POLB (0.81) ALDH1A1CYP2C19CYP1A2POLBCYP3A4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11634434-B2 Bifunctional alpha-synuclein binding agents and uses thereof UNIVERSITY OF SASKATCHEWAN (CA) 2023-04-25 US disclosed
US-20200062782-A1 BIFUNCTIONAL ALPHA-SYNUCLEIN BINDING AGENTS AND USES THEREOF UNIVERSITY OF SASKATCHEWAN (CA) 2020-02-27 US disclosed
WO-2018045464-A1 BIFUNCTIONAL ALPHA-SYNUCLEIN BINDING AGENTS AND USES THEREOF UNIVERSITY OF SASKATCHEWAN (CA) 2018-03-15 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200062782-A1 BIFUNCTIONAL ALPHA-SYNUCLEIN BINDING AGENTS AND USES THEREOF SNCA, PARK7, SYNJ2 ALDH1A1 2050/4885CYP2C19 4783/4885CYP1A2 4686/4885
US-11634434-B2 Bifunctional alpha-synuclein binding agents and uses thereof SNCA, PARK7, SYNJ2 ALDH1A1 2050/4885CYP2C19 4783/4885CYP1A2 4686/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.